Medication info
Ledopin Tablets (Lercanidipine Hydrochloride)

Ledopin Tablets (Lercanidipine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Lercanidipine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Korea Pavise Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 200805235 · Notified 2008.05.08 · Insurance code 621802210

Summary

Main use
Treatment of mild to moderate essential hypertension
Who takes it
Adults
Adult dose
○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Since it takes 2 weeks for the maximum antihypertensive effect to become apparent, adjust the dose gradually. Patients whose blood pressure is not controlled with this drug may receive combination therapy with a beta blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril, enalapril). The dose-response curve is steep and reaches its peak at a dose of 20 ~ 30 mg; therefore, administering doses above this range does not further increase efficacy and may instead increase adverse reactions. ○ Elderly patients: Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is required when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment: Special caution is required during treatment initiation in patients with mild to moderate hepatic or renal impairment. Although the usual dosage regimen for these patients is unchanged, caution is required when increasing the dose to 20 mg daily. In patients with hepatic impairment, the antihypertensive effect may be increased, and dose adjustment should therefore be considered. Do not administer this drug to patients with severe hepatic or renal impairment.

Ingredients

Manufacturer
Korea Pavise Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of mild to moderate essential hypertension

  • Essential hypertension
View approved original text

This medication is used to treat essential hypertension categorized as mild to moderate.

How to take

Adult dose

○ Adults Administer 5 ~ 10 mg of lercanidipine hydrochloride orally once daily at least 15 minutes before a meal. The dose may be increased to 20 mg according to the patient's symptoms. Since it takes 2 weeks for the maximum antihypertensive effect to become apparent, adjust the dose gradually. Patients whose blood pressure is not controlled with this drug may receive combination therapy with a beta blocker (e.g., atenolol), a diuretic (e.g., hydrochlorothiazide), or an ACE inhibitor (e.g., captopril, enalapril). The dose-response curve is steep and reaches its peak at a dose of 20 ~ 30 mg; therefore, administering doses above this range does not further increase efficacy and may instead increase adverse reactions. ○ Elderly patients: Pharmacokinetic data and clinical experience indicate that adjustment of the daily dose is not necessary; however, caution is required when initiating treatment in elderly patients. ○ Patients with hepatic or renal impairment: Special caution is required during treatment initiation in patients with mild to moderate hepatic or renal impairment. Although the usual dosage regimen for these patients is unchanged, caution is required when increasing the dose to 20 mg daily. In patients with hepatic impairment, the antihypertensive effect may be increased, and dose adjustment should therefore be considered. Do not administer this drug to patients with severe hepatic or renal impairment.

Precautions

This drug should not be used by certain patients. For example, patients with an allergy to this drug or similar drugs, pregnant or nursing women, patients with specific heart problems, patients with severe liver or kidney disease, those who have recently experienced a myocardial infarction, patients undergoing dialysis, and children and adolescents under 18 should not take this medication. This drug should be used with caution in some patients. Special caution is required for patients with heart function issues, slightly impaired kidney or liver function, past angina sufferers, those who consume alcohol frequently, and elderly individuals. When taking this medication, various side effects may occur. Symptoms may include flushing or swelling of the face, palpitations, headache, dizziness, indigestion, nausea, vomiting, altered liver function, frequent urination, inflammation of the mouth, skin rash, muscle pain, etc. If these symptoms occur, consult a physician. Sudden discontinuation of this medication may worsen symptoms, so it must be gradually reduced while closely monitoring the condition. Additionally, dizziness or drowsiness may occur during treatment, thus caution is needed while driving or operating machinery. As this medication is metabolized in the liver, the effectiveness can change when taken with certain medications. Caution is necessary when co-administering with drugs that inhibit or promote liver metabolism, and it is advisable to avoid grapefruit juice as it can elevate drug concentration. Alcohol can also enhance the blood pressure-lowering effect of this medication and should be avoided. Women who are pregnant or could become pregnant, as well as nursing women, should not take this medication and should use effective contraception. There is insufficient experience in using this medication for children and adolescents under 18, so it is considered safer not to prescribe it to them. For elderly patients, special caution is needed, but dosage adjustments are generally not required. In case of overdose, severe hypotension and rapid heartbeat may occur, for which appropriate medical treatment should be received. This medication is highly lipid-soluble, making removal through dialysis difficult, so the heart condition should be monitored for at least 24 hours in case of overdose. Finally, this medication should be stored out of reach of children, and transferring it to another container may compromise the quality of the product, so caution is advised.

Side effects

Flushing, peripheral edema, palpitations, tachycardia, hypotension, chest pain, angina, headache, dizziness, weakness, fatigue, drowsiness, neurasthenia, dyspepsia, nausea, vomiting, abdominal pain, diarrhea, elevated serum levels of liver amino transferase, polyuria, nocturia, gingival hypertrophy, rash, myalgia, tremors, insomnia, dry mouth, paresthesia, cough, abdominal bloating, erectile dysfunction, arrhythmia, sweating, skin prickling, premature contractions, tongue stiffness, increased ventricular ectopic beats, shortness of breath, gastrointestinal disturbance

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to keep it at room temperature between 1°C and 30°C, avoiding extreme heat or cold.

Appearance and packaging

Appearance

Yellow round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.